The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Microdosing psychedelics: personality, mental health, and creativity differences in microdosers
Open accessAbstract
Rationale Microdosing psychedelics-the regular consumption of small amounts of psychedelic substances such as LSD or psilocybin-is a growing trend in popular culture. Recent studies on full-dose psychedelic psychotherapy reveal promising benefits for mental well-being, especially for depression and end-of-life anxiety. While full-dose therapies include perception-distorting properties, microdosing mayprovide complementary clinical benefits using lower-risk, non-hallucinogenic doses.Objectives This pre-registered study aimed to investigate whether microdosing psychedelics is related to differences in personality, mental health, and creativity.Methods In this observational study, respondents recruited from online forums self-reported their microdosing behaviors and completed questionnaires concerning dysfunctional attitudes, wisdom, negative emotionality, open-mindedness, and mood. Respondents also performed the Unusual Uses Task to assess their creativity.Results Current and former microdosers scored lower on measures of dysfunctional attitudes (p < 0.001, r = - 0.92) and negative emotionality (p = 0.009, r = - 0.85) and higher on wisdom (p < 0.001, r = 0.88), openmindedness(p = 0.027, r = 0.67), and creativity (p < 0.001, r = 0.15) when compared to non-microdosing controls.Conclusions These findings provide promising initial evidence that warrants controlled experimental research to directly test safety and clinical efficacy. As microdoses are easier to administer than full-doses, this new paradigm has the exciting potential to shape future psychedelic research.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the data on human psychedelic microdosing are equivocal”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [245]
In the citing paper
“therapeutic benefit of low doses of psychedelics remains to be demonstrated in a well-controlled clinical study”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [245]
In the citing paper
“Interestingly, openmindesness (i.e., openness) was higher and negative emotionality (i.e., neuroticism) was lower in current and former microdosers compared to MD-naïve controls (27).”
From Trait mindfulness and personality characteristics in a microdosing ADHD sample: a naturalistic prospective survey study (2023) · cites this paper as [27]
Citations
Cites
The broaden–and–build theory of positive emotions
Fredrickson, B. L. (2004) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2004.1512 · Cited by 4,214
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201
Soto, C. J., & John, O. P. (2017) · Journal of Personality and Social Psychology · doi:10.1037/pspp0000096 · Cited by 2,075
Public health significance of neuroticism
Lahey, B. B. (2009) · American Psychologist · doi:10.1037/a0015309 · Cited by 1,901 · cited 1×
“Tendencies to experience negative emotionality (e.g., anxiety, depression, and emotional volatility) are a robust predictor of mental and physical health problems (Lahey 2009) thus reduced vulnerability is reflected in the lower scores seen in microdosers.”
BackgroundRoss, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565144 · Cited by 1,151
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., & Jesse, R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2358-5 · Cited by 932
Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction
Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114548296 · Cited by 914
Silvia, P. J., Winterstein, B. P., Willse, J. T., Barona, C. M., Cram, J. T., Hess, K. I., Martinez, J. L., & Richard, C. A. (2008) · Psychology of Aesthetics, Creativity, and the Arts · doi:10.1037/1931-3896.2.2.68 · Cited by 912
MacLean, K. A., Johnson, M. W., & Griffiths, R. R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111420188 · Cited by 895
Research works printed but not linked: 2
- Fadiman J (2011) The psychedelic explorer’s guide. Park Street Press, Rochester
- Waldman A (2017) A really good day: how microdosing made a mega difference in my mood, my marriage, and my life, 1st edn. Knopf, New York
Cited by
Sorted by citations
Items 101–174 of 174
Neuroenhancement: State of the Art and Future Perspectives.
Marazziti, D., Avella, M. T., Ivaldi, T., Palermo, S., Massa, L., Vecchia, A. D., Basile, L., & Mucci, F. (2021) · PubMed Central · doi:10.36131/cnfioritieditore20210303 · Cited by 6
Using Psychedelics in Clinical Practice: Comparing Therapeutic Uses and Potential Harms
Tariq, R. (2022) · Current Clinical Pharmacology · doi:10.2174/2772432817666220321142707 · Cited by 5
Managing expectations with psychedelic microdosing
Syed, O. A., & Tsang, B. (2023) · npj Mental Health Research · doi:10.1038/s44184-023-00044-9 · Cited by 5
Walker, C., Piatkowski, T. M., Ferris, J., Davies, E., Barratt, M. J., WINSTOCK, A. R., & Puljević, C. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241265762 · Cited by 5
Kiilerich, K. F., Lorenz, J., Scharff, M. B., Speth, N., Brandt, T. G., Czurylo, J., Xiong, M., Jessen, N. S., Casado-Sainz, A., Shalgunov, V., et al. (2023) · doi:10.31219/osf.io/gy6m9 · Cited by 5
Rominger, C., & Subow, C. (2025) · PLoS ONE · doi:10.1371/journal.pone.0320755 · Cited by 4
Effects of psychedelics on human oscillatory brain activity
Godfrey, K. E. M., Luan, L., & Timmermann, C. (2025) · International review of neurobiology · doi:10.1016/bs.irn.2025.04.012 · Cited by 4
Prochazkova, L., Marschall, J., van Elk, M., Rifkin, B. D., Schon, N. R., Fiacchino, D., Fejer, G., Kuchař, M., & Hommel, B. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110732 · Cited by 9
Tully, J. L., Bridge, O., Rennie, J., Krecké, J., & Stevens, T. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1356496 · Cited by 4
Microdosing Psychedelics as a Promising New Pharmacotherapeutic
Kuypers, K. P. C. (2021) · Springer eBooks · doi:10.1007/978-3-030-62351-7_18 · Cited by 4
Microdosing psychedelics – Does it have an impact on emodiversity?
Pop, I. A., & Dinkelacker, J. (2023) · Journal of Psychedelic Studies · doi:10.1556/2054.2022.00208 · Cited by 4
Microdosing as a response to the meaning crisisPreprint
Petranker, R., Kim, J. J., & Anderson, T. (2020) · doi:10.31234/osf.io/2jnkf · Cited by 4
Self-citationProchazkova, L., van Elk, M., Marschall, J., Rifkin, B. D., Fejer, G., Schon, N. R., Fiacchino, D., Kuchař, M., & Hommel, B. (2021) · doi:10.31234/osf.io/emcxw · Cited by 4
Beyond prohibition: A public health analysis of naturalistic psychedelic use
Haden, M., Paschall, S. A., & Woods, B. (2025) · Journal of Psychedelic Studies · doi:10.1556/2054.2025.00450 · Cited by 3
Cyborg Virtues: Using Brain Stimulation for Moral Enhancement
Hughes, J. J. (2023) · Advances in neuroethics · doi:10.1007/978-3-031-26801-4_9 · Cited by 3
How Psychoactive Drugs and the Circadian Clock Are Enlightening One Another
Engmann, O. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-81147-1_8 · Cited by 3
Lysergic acid diethylamide–associated intoxication in Hong Kong: a case series
Li, C., Tang, M. H. Y., Chong, Y., Chan, T. Y., & Mak, T. W. (2019) · Hong Kong Medical Journal · doi:10.12809/hkmj197942 · Cited by 3
Hallucinogen Use in College Students: Current Trends and Consequences of Use
Jia, L. S., & Gold, J. A. (2020) · Current Psychopharmacologye · doi:10.2174/2211556009666200311140404 · Cited by 3
Psychedelics and schizophrenia: A mystery in history
Haden, M., Woods, B., & Paschall, S. A. (2023) · Journal of Psychedelic Studies · doi:10.1556/2054.2023.00277 · Cited by 6
From Outsider to Insider: A Look at the Subculture of Microdosing
Beaton, B., & Gerber, J. (2024) · Deviant Behavior · doi:10.1080/01639625.2024.2336198 · Cited by 2
Exploring a Decade of Microdosing Research: A Qualitative Meta-synthesis of Microdosing Literature
Beaton, B. (2026) · Deviant Behavior · doi:10.1080/01639625.2026.2624690 · Cited by 2
Holas, P., Kamińska, J., & Zajenkowski, M. (2025) · Dialogues in Clinical Neuroscience · doi:10.1080/19585969.2025.2470426 · Cited by 2
Hypnosis, Psychedelics, and Creativity: An Overview and Analysis
Attig, S., & Krippner, S. (2025) · International Journal of Clinical and Experimental Hypnosis · doi:10.1080/00207144.2025.2555431 · Cited by 2
An Overview of Alkaloids Derived from Tryptophan and Their Potential Antidepressant Action
Lima, M. E. D., da Silva, I. S., Desmarais, M. D. O. L., de Oliveira, T. C., Moreira, D. D. L., & Valverde, A. L. (2021) · Revista Virtual de Química · doi:10.21577/1984-6835.20210055 · Cited by 2
Polito, V., & Liknaitzky, P. (2021) · doi:10.31234/osf.io/edhqz · Cited by 2
Evidence for tolerance in psychedelic microdosing from the self-blinding microdose trialPreprint
Baumann, S., Carhart-Harris, R. L., Nutt, D. J., Erritzøe, D., & Szigeti, B. (2022) · doi:10.31234/osf.io/s4qhf · Cited by 2
Facilitating real-life creative insight through psychedelic virtual realityPreprint
Siimon, T., Tulver, K., Kaup, K., Vasser, M., & Aru, J. (2023) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/zth7f · Cited by 4
Pierre, M. S., Argento, E., Cates, J., Kryskow, P., Harvey, K., Stamets, P. E., Santos-Brault, E., Paschall, S. A., Kuypers, K. P. C., Rootman, J. M., et al. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06913-9 · Cited by 1
Smith, G., Piatkowski, T. M., Ferris, J., Bonenti, B., Davies, E., Barratt, M. J., Morgan, C. J. A., WINSTOCK, A. R., & Puljević, C. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251378509 · Cited by 1
Wojciechowski, T. W. (2025) · Substance Use & Misuse · doi:10.1080/10826084.2025.2603681 · Cited by 1
Beidas, Z., Ragnhildstveit, A., Blackman, A., Anderson, T., Fewster, E. C., Syed, O. A., Sobolenko, V., Kanca, I. K., Jaglinska, M., Son, T., et al. (2026) · BJPsych Open · doi:10.1192/bjo.2025.10968 · Cited by 1
Self-citationÖzaydın, Y., & Ozaydin, B. C. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261456196 · Cited by 1
Petranker, R., Syed, O. A., Sobolenko, V., Giacobbe, P., Kruger, D. J., Aday, J. S., Lake, S., & Lucas, P. (2026) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2026.105459 · Cited by 1
Self-citationGolia, K. (2022) · Consciousness Spirituality & Transpersonal Psychology · doi:10.53074/cstp.2022.37 · Cited by 1
Vitalism and Naturopathy in Psychedelic Medicine.
Hicks, M., & Giguere, O. (2024) · PubMed Central · Cited by 1
Brief Wisdom Screening Scale: Multi-sample factor analysis and validationPreprint
Anderson, T. (2020) · doi:10.31234/osf.io/2mszf · Cited by 1
Self-citationWhat Are the Appropriate Boundaries of Imagination?
Ellison, J. M., & Kyomen, H. H. (2019) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.05.007
Psilocybin's effects on the brain and implications for depression treatment
Sarajärvi, K. (2020) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Osobnostní rozvoj při zotavování se ze závislosti na omamných látkách
Olivová, A., & Slezáčková, A. (2021) · E-psychologie · doi:10.29364/epsy.393
Enhancing Our Ability to Design
Reis, J. (2022) · Springer eBooks · doi:10.1007/978-3-030-95782-7_8
Hollander, E., & Uzunova, G. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735236753.793581300
Pritzker, S. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.23844-3
Heinrichs, J.-H., Rüther, M., Stake, M., & Ihde, J. (2022) · Verlag Karl Alber eBooks · doi:10.5771/9783495999615-9
I. Neuroenhancement – a short introduction on medical options
Heinrichs, J.-H., Rüther, M., Stake, M., & Ihde, J. (2022) · Verlag Karl Alber eBooks · doi:10.5771/9783495999615-13
II. Ethics of Neuroenhancement
Heinrichs, J.-H., Rüther, M., Stake, M., & Ihde, J. (2022) · Verlag Karl Alber eBooks · doi:10.5771/9783495999615-33
Heinrichs, J.-H., Rüther, M., Stake, M., & Ihde, J. (2022) · Verlag Karl Alber eBooks · doi:10.5771/9783495999615-1
Heinrichs, J.-H., Rüther, M., Stake, M., & Ihde, J. (2022) · Verlag Karl Alber eBooks · doi:10.5771/9783495999615-118
Well-Being and the Outdoors: An Environmentalism Study Among a Religious Student Population
Pires-Gifford, L., Hoffmann, S., Arroyo, E., Jones, N., Waite, B., & Wright, R. R. (2022) · Psi Chi Journal of Psychological Research · doi:10.24839/2325-7342.jn27.3.185
Wright, R. R., Treadwell, K. R. H., & Hughes, J. L. (2022) · Psi Chi Journal of Psychological Research · doi:10.24839/2325-7342.jn27.3.223 · Cited by 1
Caldararo, N. (2022) · Springer eBooks · doi:10.1007/978-3-031-13745-7_2
Nano Forensic Testing of Illicit Drugs
Riaz, A., Zareef, I., Munawar, A., Rakha, A., & Shad, N. A. (2023) · Advances in digital crime, forensics, and cyber terrorism book series · doi:10.4018/978-1-6684-8325-1.ch011
Garcia, V. M. P. (2023) · Cultura y Droga · doi:10.17151/culdr.2023.28.35.9
Tendencias y experiencias del consumo de microdosis de hongos psilocibios en Colombia
Suárez, C., Quintero, S., & Gil, J. M. C. (2023) · Cultura y Droga · doi:10.17151/culdr.2023.28.35.7 · Cited by 1
Investigación sobre microdosificación con hongos psilocibios: un artículo de reflexión
Duque, L. (2023) · Cultura y Droga · doi:10.17151/culdr.2023.28.35.3
Explain of Students Creativity Based on Spiritual Happiness with Mediating Role of Perfectionism
Mehr, F. M., Afrooz, G. A., & Davaee, M. (2023) · doi:10.61838/kman.jayps.4.1.4
Ferreira, A. S. M., Martindale, S., & Luke, D. P. (2024) · Journal of Psychedelic Studies · doi:10.1556/2054.2024.00368
Microdosing Psychedelics as a Promising New Pharmacotherapeutic
Kuypers, K. P. C. (2024) · Springer eBooks · doi:10.1007/978-3-031-61992-2_26
Totomanova, I., Haijen, E. C. H. M., Hurks, P. P. M., Ramaekers, J. G., & Kuypers, K. P. C. (2025) · International review of neurobiology · doi:10.1016/bs.irn.2025.03.002
Psychedelics’ Intoxicating Impact and Behavioural Dynamics
Wasti, A. Z. (2025) · Pharmaceutical science. · doi:10.5772/intechopen.1011743
“It Fueled the Fire to Who I Am Now”: Exploring Motivations for Microdosing Psychedelics
Beaton, B. (2025) · Journal of Drug Issues · doi:10.1177/00220426251395178
Murphy, R. J., Wardlaw, M., Smith, T., Noorani, T. N., Evans, W., Reynolds, L., Menkes, D. B., Sumner, R. L., & Muthukumaraswamy, S. D. (2025) · Journal of Humanistic Psychology · doi:10.1177/00221678251382624
Bansal, M., Miller, E., Sumner, R. L., Ponton, R., Muthukumaraswamy, S., & Svirskis, D. M. (2025) · Journal of Chromatographic Science · doi:10.1093/chromsci/bmaf054
Wells, A., Muthukumaraswamy, A. P. S., Morunga, E., Evans, W., Cavadino, A., Bansal, M., Lawrence, N. J., Ashley, A., Hoeh, N. R., Sundram, F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25210532
Wells, A., Muthukumaraswamy, A. P. S., Morunga, E., Evans, W., Cavadino, A., Bansal, M., Lawrence, N. J., Ashley, A., Hoeh, N. R., Sundram, F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25210812
Ryan, R. S., Copello, A., & Fox, A. P. (2024) · Figshare · doi:10.6084/m9.figshare.26575175
Murphy, R. J., Sumner, R. L., Evans, W. J., Menkes, D., Lambrecht, I., Ponton, R., Sundram, F., Hoeh, N. R., Ram, S., Reynolds, L., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14478492
Banzato, M., Colognesi, M., Lucatello, L., Comai, S., Pasut, G., Capolongo, F., Orian, L., Biasutto, L., Signor, A., Gabbia, D., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01797
Altered States of Consciousness Modulate Aesthetic Processing in Naturalistic Art ViewingPreprint
Taskiran, E., Gazzola, T., Polo, A., Signorelli, A., & Pisapia, N. D. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.6137474
Gu, E. Y., Irvine, N. M., Miller, M. J., Ramirez, E., Santaella-Tenorio, J., Lippincott, T., Bogenschutz, M. P., Bunting, A. M., Meacham, M. C., & Krawczyk, N. (2026) · Journal of Psychedelic Studies · doi:10.1556/2054.2026.00487
Classic psychedelics and personality: An updated systematic review
Vicentini, A. B., de Paula, C. C., Reis, J. A. S., Bouso, J. C., Hallak, J. E. C., & SANTOS, R. G. D. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261449386
Psilocybin and Mental Health Outcomes: Scoping Review with ☸️SAIMSARA
SAIMSARA (2026) · SAIMSARA Journal · doi:10.62487/saimsara7a54f680
Meshkat, S., Leung, M., Meshkat, S., Lin, Q., Wijendran, D., Reichelt, A. C., Zhang, Y., Burback, L., Winkler, O., Greenshaw, A. J., et al. (2026) · CNS Drugs · doi:10.1007/s40263-026-01325-5
Metadata
- Authors
- Anderson, T., Petranker, R., Rosenbaum, D., Weissman, C. R., Dinh-Williams, L.-A., Hui, K., Hapke, E., & Farb, N. A. S.
- Affiliations
- University of Toronto (CA)
- York University (CA)
- Centre for Addiction and Mental Health (CA)
- Corresponding author
- Anderson, Thomas
- Petranker, Rotem
- ORCID
- Venue
- Psychopharmacology
- Published
- 2019-01-02
- Volume
- 236
- Issue
- 2
- Pages
- 731-740
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2907379922
- Cited by
- 174
- References
- 39
- Citations by year
- 2026: 11 · 2025: 21 · 2024: 26 · 2023: 22 · 2022: 28 · 2021: 24 · 2020: 22 · 2019: 18
- FWCI
- 26.86
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- PsyArXiv (OSF Preprints) (submittedVersion)
- PsyArXiv (OSF Preprints) (submittedVersion, cc-by)
- OSF Preprints (OSF Preprints) (submittedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Social Sciences › Psychology › Social Psychology › Paranormal Experiences and Beliefs
- Social Sciences › Psychology › Social Psychology › Psychological Well-being and Life Satisfaction
- Keywords
- microdosing, psychedelics, LSD, psilocybin, personality, mental health, creativity, dysfunctional attitudes, negative affectivity, wisdom, open-mindedness, mood
- MeSH terms
- Adult, Anxiety, Creativity, Depression, Dose-Response Relationship, Drug, Emotions, Female, Hallucinogens, Humans, Lysergic Acid Diethylamide, Male, Mental Health, Perception, Personality, Psilocybin, Surveys and Questionnaires
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review